𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin

✍ Scribed by W. H. De Jong; E. C. De Boer; A. P. M. Van Der Meijden; P. Vegt; P. A. Steerenberg; F. M. J. Debruyne; E. J. Ruitenberg

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
664 KB
Volume
31
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of action of bacillus Calmett
Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer
✍ J. J. Patard; D. K. Chopin; L. Boccon-Gibod 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 375 KB

Local immunotherapy with bacillus Calmette-Guérin (BCG) is an effective treatment to prevent recurrence and progression of superficial bladder cancer, but the antitumor mechanism of action of BCG remains unclear. There are some experimental and clinical data suggesting that BCG antigens are processe

Urinary IL-2 assay for monitoring intrav
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy
✍ Fabien Saint; Nathalie Kurth; Pascale Maille; Dimitri Vordos; Andre Hoznek; Pasc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 670 KB

## Abstract We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bl

The prognostic value of cytology and flu
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
✍ Spasenija Savic; Inti Zlobec; George N. Thalmann; Daniel Engeler; Martina Schmau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB

## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc